Innventure Forms Committee to Review Capital Amid Funding Needs of at Least $50 Million
Key Facts
Innventure announced on November 2, 2026, that it had formed a committee of independent members to review capital strategies and other strategic priorities, as the parent company faces near-term liquidity requirements. The company said most cash reported on its consolidated balance sheet belongs to Accelsius, limiting cash available at the parent-company level. The committee will work with independent financial advisers on a comprehensive review, which the company did not say when it expects to complete. It added that no decisions had been made about potential actions. The announcement comes as the group reviews its funding needs and cuts spending at the parent-company level.
Innventure’s estimates in its quarterly report show that its operating and strategic needs for the twelve months following June 30, 2026, total at least $50 million. The company also estimated that it could need up to an additional $25 million to support subsidiaries if they are unable to raise funding independently. In the six months ended June 30, 2026, Innventure reported a net loss of $62.7 million, compared with $34.9 million in the same period of 2025. Cash used in operating activities was $59.5 million, up from $36.8 million a year earlier, an increase of 61.8%. Management said in the report that the financial conditions “raise substantial doubt” about the company’s ability to continue as a going concern within one year of the financial statements’ issuance.
The cost-cutting measures announced by the company are a parallel response to liquidity pressure. Headcount has fallen from 40 to 15 since the end of the first quarter, and Innventure said this reduced payroll costs by about 57%, excluding termination costs. In September, the company said it was targeting a reduction in quarterly parent-company cash expenses to about $3.2 million by the end of 2026, compared with $7.5 million at the start of the year, a decline of about 56%. That same month, it announced that it was refocusing its primary efforts on Accelsius’s market success while cutting spending at the parent-company level. This places the parent company’s needs alongside its plan to continue supporting subsidiaries, while giving Accelsius greater room in the group’s strategy.
At the subsidiary level, Accelsius has engaged Evercore Group as a financial adviser to assess its needs and private-capital formation alternatives. Innventure, meanwhile, is targeting an end to funding for AeroFlexx during the month following the announcement and an end to funding for Refinity by the end of 2026. It said it continues to seek potential sales and interim third-party funding for both companies. Refinity had previously backed away from a plan to rely on self-funding starting in October 2026. Innventure said limited near-term funding would give the subsidiary more time to reach an outcome that could preserve or generate shareholder value.
The company faces a choice between raising liquidity through equity issuance and limiting dilution for shareholders. On October 6, it established an at-the-market equity offering program with a maximum of $60 million, but said it does not intend to use it to fund Accelsius at current share prices or to raise the full amount available. It described the program as an alternative to a $75 million standby equity purchase agreement it entered into in 2023, and said it does not increase the total capital it intends to raise. Innventure said in August that it was considering alternatives including debt and equity financing and asset monetization, with the aim of limiting dilution while addressing its capital needs. The company’s shares, listed under the ticker INV, closed at $0.3198 on October 30, according to EL7 data.
The review committee consists of disinterested members, while the company said its board has 7 directors, including 6 independent directors, after being reduced from 9 members. Innventure did not set a timeline for completing the review and did not announce any specific action it would take. The company plans to end funding for AeroFlexx during the month following the November 2 announcement and for Refinity by the end of 2026, while continuing to seek sales and interim funding for both. The review committee will continue to assess capital strategies and other priorities, with no announced completion date. Any subsequent steps will depend on the review’s findings and the funding available to the parent company and its subsidiaries.